Literature DB >> 16995845

A case of T/null anaplastic large cell lymphoma arising in lung.

Zenaida Cerimagić1, Safet Guska, Bedrudin Banjanović.   

Abstract

Anaplastic large cell lymphoma (ALCL) is a rare non-Hodgkin, T-cell lymphoma, representing only 2-3% of all lymphoid neoplasm's in adults according to World Health Organization (WHO). CD30 antigen-positive, large neoplastic cells characterize ALCL. We present here a 46-year-old male with pulmonary ALCL previously diagnosed with Hodgkin disease. Microscopically, atypical bi-and multinucleated cells with frequent mitoses were present. The neoplastic cells were large and had clear cytoplasm, large vesicular nuclei, and prominent nucleoli. Immunophenotypic analysis revealed LCA, vimentin and CD30 positivity. ALK immunostaining was negative. Immunohistochemical profile was consistent with ALK negative ALCL. The progression of Hodgkin lymphoma to aggressive non-Hodgkin lymphoma (ALCL in this case) is well known entity. After the diagnosis was established, our patient immediately had been referred to the Department of Hematology in order to get appropriate chemotherapy, necessary in such cases.

Entities:  

Mesh:

Year:  2006        PMID: 16995845      PMCID: PMC7193659          DOI: 10.17305/bjbms.2006.3141

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  7 in total

1.  Expression of the ALK protein by anaplastic large-cell lymphomas correlates with high proliferative activity.

Authors:  L Leoncini; S Lazzi; D Scano; A Mura; A Onida; G Massarelli; P Tosi; P Barbini; G Cevenini; M R Massai; S Pileri; B Falini; A Giordano; R Kraft; J A Laissue; H Cottier
Journal:  Int J Cancer       Date:  2000-06-15       Impact factor: 7.396

2.  Posttransplant CD30 (Ki-1)-positive anaplastic large cell lymphoma. Report of a case with presentation as a pleural effusion.

Authors:  J A Jiménez-Heffernan; J M Viguer; B Vicandi; V Jiménez-Yuste; J Palacios; F Escuin; C Gamallo
Journal:  Acta Cytol       Date:  1997 Sep-Oct       Impact factor: 2.319

3.  A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma ('Ki-1 lymphoma').

Authors:  R Rimokh; J P Magaud; F Berger; J Samarut; B Coiffier; D Germain; D Y Mason
Journal:  Br J Haematol       Date:  1989-01       Impact factor: 6.998

4.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

5.  Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project.

Authors: 
Journal:  Ann Oncol       Date:  1997-10       Impact factor: 32.976

Review 6.  Molecular biology of anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma.

Authors:  Jeffery L Kutok; Jon C Aster
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

7.  A case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting with spontaneous splenic rupture: an extremely unusual presentation.

Authors:  K M Hebeda; M A MacKenzie; J H van Krieken
Journal:  Virchows Arch       Date:  2000-10       Impact factor: 4.064

  7 in total
  3 in total

1.  Primary pulmonary anaplastic large cell lymphoma: case report and literature review.

Authors:  Weina Li; Fenggang Li; Jingxue Chu; Shuping Liu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

2.  Anaplastic large cell lymphoma in a patient with rheumatoid arthritis.

Authors:  Cemal Bes; Z Senem Bes; Seref Vardı; Mehmet Soy
Journal:  Rheumatol Int       Date:  2009-10-23       Impact factor: 2.631

Review 3.  Successful Chemo-Radiotherapy for Primary Anaplastic Large Cell Lymphoma of the Lung: A Case Report and Literature Review.

Authors:  Qian Zhao; Yongmei Liu; Huijiao Chen; Yan Zhang; Zedong Du; Jin Wang; Yongsheng Wang
Journal:  Am J Case Rep       Date:  2016-02-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.